Protein tyrosine kinases (PTK) play critical roles in normal lymphohematopoiesis, and they have also been implicated as oncoproteins in the development of B-lineage lymphoid malignancies, including leukemias, lymphomas, and MM [15-17]. This evidence concerns the gene PTK2B and Miyoshi myopathy.